{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:54:06Z","timestamp":1778054046150,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T04:34:01Z","timestamp":1324269241000},"page":"D70-D73","source":"Crossref","is-referenced-by-count":35,"special_numbering":"S4","title":["The principles and feasibility of disease eradication"],"prefix":"10.1016","volume":"29","author":[{"given":"Walter R.","family":"Dowdle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.04.006_bib0005","first-page":"535","article-title":"Principles and lessons from the smallpox eradication programme","volume":"65","author":"Henderson","year":"1987","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0010","series-title":"Vaccines: preventing disease and protecting health","first-page":"354","article-title":"Perspectives for elimination\/eradication of diseases with vaccines","author":"Dowdle","year":"2004"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0015","series-title":"The oxford dictionary and thesaurus (American edition)","year":"1996"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2105\/AJPH.52.5.734","article-title":"Problems to be solved if the eradication of tuberculosis is to be realized","volume":"52","author":"Soper","year":"1962","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2105\/AJPH.53.1.1","article-title":"The philosophy of disease eradication","volume":"53","author":"Andrews","year":"1963","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0030","first-page":"502","article-title":"Prospects for disease eradication or elimination","volume":"84","author":"Hinman","year":"1984","journal-title":"N Y State J Med"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0035","first-page":"1","article-title":"Recommendations of the International Task Force for Disease Eradication","volume":"42","author":"CDC (Centers for Disease Control and Prevention)","year":"1993","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0040","series-title":"The eradication of infectious diseases","first-page":"47","article-title":"Group report: how is eradication to be defined and what are the biological criteria?","author":"Ottesen","year":"1998"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0045","first-page":"113","volume":"76","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1072266","article-title":"Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template","volume":"297","author":"Cello","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2968\/065002004","article-title":"How biodevelopment can enhance biosecurity","volume":"65","author":"Singer","year":"2009","journal-title":"Bull Atomic Scientists"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0060","first-page":"490","article-title":"Monitoring progress towards measles elimination","volume":"85","author":"WHO (World Health Organization)","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0065","first-page":"125","article-title":"Elimination of Yaws in India","volume":"83","author":"WHO (World Health Organization)","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0070","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2010.10.026","article-title":"Economic analysis of the global polio initiative","volume":"29","author":"Duintjer Tebbens","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0080","first-page":"445","article-title":"Outbreaks following importations of wild poliovirus into countries of WHO African, European, and South\u2013East Asian regions: January 2009\u2013September 2010","volume":"85","author":"WHO (World Health Organization)","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0085","first-page":"683","article-title":"Eradication versus control: the economics of global infectious disease policies","volume":"82","author":"Barrett","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0090","series-title":"The eradication of infectious diseases","year":"1998"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.04.006_bib0095","first-page":"1","article-title":"Global disease elimination and eradication as public health strategies","volume":"76","author":"WHO (World Health Organization)","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2105\/AJPH.90.10.1515","article-title":"When is a disease eradicable? 100 years of lessons learned","volume":"90","author":"Aylward","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0105","series-title":"The eradication of infectious diseases","first-page":"19","article-title":"Lessons from previous eradication programs","author":"Hinman","year":"1998"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bmj.331.7527.1262","article-title":"The animal story","volume":"331","author":"Roeder","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0115","unstructured":"Polio Research Committee: conclusions and recommendations. The Polio Pipeline 2010;5:1\u20135. polioresearch@who.int."},{"key":"10.1016\/j.vaccine.2011.04.006_bib0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2471\/BLT.08.060863","article-title":"Achieving polio eradication: a review of health communications evidence and lessons learned in India and Pakistan","volume":"87","author":"Obregon","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 poliovirus vaccine: a randomized, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1539-6924.2006.00843.x","article-title":"Evaluation of response scenarios to potential polio outbreaks using mathematical models","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2011.04.006_bib0135","unstructured":"Hopkins DR. The allure of eradication. In: Global Health Magazine 2009;3:14\u20137. www.globalhealthmagazine.com."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T12:26:57Z","timestamp":1543321617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"alternative-id":["S0264410X11005160"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}